CD8A and neoplasm: FCM analysis revealed that IPI549@HMP-based RT effectively enhanced the frequency of tumor-infiltrating CD8+ T cells and reduced MDSCs and TAMs-M2 compared with other controls (Fig. 6a–f and Supplementary Fig. 20).